For the first time, we can now determine quantitative microvascular scores that correlate very well with accepted clinical parameters in individual sepsis patients for a wide range of clinical severitie.
CEO, William Resides announces that as of July 1st, 2022, BioRegenx has moved from due diligence to a binding letter of intent to merge with a public company. These steps also include drafting the definitive agreement for the final merger.
The benefits of PEMF (Pulsed Electro-Magnetic Field) therapy is no secret among wellness experts with a four-year study conducted by NASA to understand its benefits and effects on human wellbeing. NuLife Sciences introduces a portable and affordable PEMF therapy device called the Sedona Face.
VNox+ was carefully crafted for NuLife Sciences to support the production of nitric oxide in the body. The discovery that nitric oxide (NO) is a signaling molecule in the cardiovascular system whereby dilating blood vessels was awarded a Nobel Prize in Physiology or Medicine in 1998.